Parkman Healthcare Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.7M | Buy |
225,875
+95,508
| +73% | +$8.34M | 2.27% | 13 |
|
|
2025
Q1 | $8.9M | Buy |
130,367
+51,817
| +66% | +$3.54M | 1.06% | 36 |
|
|
2024
Q4 | $6.11M | Buy |
78,550
+7,962
| +11% | +$619K | 0.81% | 41 |
|
|
2024
Q3 | $4.73M | Sell |
70,588
-86,267
| -55% | -$5.78M | 0.6% | 54 |
|
|
2024
Q2 | $17.8M | Sell |
156,855
-14,810
| -9% | -$1.68M | 2.38% | 10 |
|
|
2024
Q1 | $23.8M | Sell |
171,665
-53,950
| -24% | -$7.48M | 2.92% | 7 |
|
|
2023
Q4 | $28M | Sell |
225,615
-39,903
| -15% | -$4.95M | 3.94% | 4 |
|
|
2023
Q3 | $24.8M | Buy |
265,518
+180,392
| +212% | +$16.8M | 4.54% | 4 |
|
|
2023
Q2 | $10.9M | Buy |
85,126
+6,199
| +8% | +$797K | 1.9% | 16 |
|
|
2023
Q1 | $9.17M | Buy |
78,927
+16,197
| +26% | +$1.88M | 1.99% | 17 |
|
|
2022
Q4 | $7.1M | Buy |
62,730
+22,372
| +55% | +$2.53M | 1.89% | 14 |
|
|
2022
Q3 | $3.25M | Buy |
40,358
+5,524
| +16% | +$445K | 0.92% | 40 |
|
|
2022
Q2 | $2.6M | Sell |
34,834
-16,114
| -32% | -$1.2M | 0.96% | 37 |
|
|
2022
Q1 | $6.52M | Sell |
50,948
-80,676
| -61% | -$10.3M | 1.91% | 19 |
|
|
2021
Q4 | $17.7M | Sell |
131,624
-50,208
| -28% | -$6.74M | 3.9% | 5 |
|
|
2021
Q3 | $24.9M | Sell |
181,832
-20,000
| -10% | -$2.73M | 6.29% | 1 |
|
|
2021
Q2 | $21.5M | Buy |
201,832
+50,960
| +34% | +$5.44M | 4.71% | 2 |
|
|
2021
Q1 | $13.6M | Sell |
150,872
-15,240
| -9% | -$1.37M | 3.15% | 7 |
|
|
2020
Q4 | $15.4M | Buy |
166,112
+47,836
| +40% | +$4.42M | 3.93% | 1 |
|
|
2020
Q3 | $12.2M | Sell |
118,276
-11,964
| -9% | -$1.23M | 3.23% | 5 |
|
|
2020
Q2 | $13.2M | Buy |
130,240
+2,108
| +2% | +$214K | 3.72% | 4 |
|
|
2020
Q1 | $8.63M | Sell |
128,132
-11,868
| -8% | -$799K | 4% | 6 |
|
|
2019
Q4 | $7.66M | Buy |
+140,000
| New | +$7.66M | 2.21% | 17 |
|